Cytodyn, Inc.
Clinical trials sponsored by Cytodyn, Inc., explained in plain language.
-
New combo aims to shrink Hard-to-Treat colon tumors
Disease control Recruiting nowThis study tests whether adding the experimental drug leronlimab to standard chemotherapy can shrink tumors in people with a common type of advanced colorectal cancer that has stopped responding to prior treatments. About 60 adults with microsatellite stable (MSS) metastatic colo…
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated May 16, 2026 23:35 UTC
-
New hope for advanced breast cancer patients: expanded access to investigational drug leronlimab
Disease control AVAILABLEThis program offers investigational leronlimab to adults with advanced or metastatic triple-negative breast cancer who have run out of standard treatment options. Participants must have confirmed HR-/HER2- cancer and have progressed on prior therapy. The goal is to provide potent…
Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated May 16, 2026 23:17 UTC